Evidence map›Paper›PMID 38798451›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Cell autonomous microglia defects in a stem cell model of frontotemporal dementia.

Abhirami K Iyer, Lisa Vermunt, Farzaneh S Mirfakhar, Miguel Minaya, Mariana Acquarone, Rama Krishna Koppisetti, Arun Renganathan, Shih-Feng You, Emma P Danhash, Anthony Verbeck and 11 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Abhirami K IyerDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Lisa VermuntNeurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam Neuroscience, VU University, Amsterdam UMC, The Netherlands.
Farzaneh S MirfakharDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Miguel MinayaDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Mariana AcquaroneDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Rama Krishna KoppisettiDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Arun RenganathanDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Shih-Feng YouDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Emma P DanhashDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Anthony VerbeckDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Grant GalassoDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Scott M LeeDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Jacob MarshDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Alissa L NanaDepartment of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Salvatore SpinaDepartment of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
William W SeeleyDepartment of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Lea T GrinbergDepartment of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Sally TempleNeural Stem Cell Institute, Albany NY.
Charlotte E TeunissenNeurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam Neuroscience, VU University, Amsterdam UMC, The Netherlands.
Chihiro SatoDepartment of Neurology, Washington University in St Louis, St Louis, MO, USA.
Celeste M KarchDepartment of Psychiatry, Washington University in St Louis, St Louis, MO, USA.ORCID 0000-0002-6854-5547

Funding

Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI ADAM L. BOXER · 2019 to 2026
$120.9M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Early Onset AD Consortium - the LEAD Study (LEADS)U01AG057195 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI APOSTOLOVA, LIANA G, CARRILLO, MARIA C · 2018 to 2023
$70.3M
TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Katherine P Rankin · 2019 to 2026
$36.9M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Susan Lynn Stark · 2020 to 2026
$28.7M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
Tau Metabolism in FTD: From Gene Mutations to Molecular Chaperones and Lysosomal ProteasesU54NS123985 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGARD, DAVID A., KAO, AIMEE · 2021 to 2025
$9.0M
iPSC Modeling of AD Using ProgerinR01AG056293 · NIA · REGENERATIVE RESEARCH FOUNDATION · PI TEMPLE, SALLY · 2017 to 2021
$2.5M
Targeting Tau Proteoforms in Frontotemporal DementiaRF1NS110890 · NINDS · WASHINGTON UNIVERSITY · PI KARCH, CELESTE MARIE · 2021 to 2021
$1.8M
Zeiss LSM 980 Airyscan 2 Microscope for Shared Mental Health ResearchS10MH126964 · NIMH · WASHINGTON UNIVERSITY · PI PISTON, DAVID W · 2021 to 2021
$600k
Tau Kinetics in the human CNS in vivo and in vitroK01AG062796 · NIA · WASHINGTON UNIVERSITY · PI SATO, CHIHIRO · 2019 to 2022
$477k
NCATS NIH HHS UL1 TR002345NIA NIH HHS K01 AG062796NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG062422NIA NIH HHS P30 AG066444NIA NIH HHS R01 AG056293NIA NIH HHS U01 AG057195NIA NIH HHS U19 AG063911NIGMS NIH HHS P41 GM103422NIMH NIH HHS S10 MH126964NINDS NIH HHS RF1 NS110890NINDS NIH HHS U54 NS123985
6 · The paper itself

Abstract

Neuronal dysfunction has been extensively studied as a central feature of neurodegenerative tauopathies. However, across neurodegenerative diseases, there is strong evidence for active involvement of immune cells like microglia in driving disease pathophysiology. Here, we demonstrate that tau mRNA and protein are expressed in microglia in human brains and in human induced pluripotent stem cell (iPSC)-derived microglia like cells (iMGLs). Using iMGLs harboring the

Identifiers

PMID38798451
PMCPMC11118656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.